Role of genetic factors in the pathophysiology and management of osteoporosis

Clinical Endocrinology

Volumn 54, Issue 1, 2001, Pages 1-9

  Hobson, Emma E ^a   Ralston, Stuart H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; CYTOKINE; ESTROGEN RECEPTOR ALPHA; OSTEOCALCIN; VITAMIN D RECEPTOR;

BONE DEMINERALIZATION; BONE DENSITY; BONE MASS; COLLAGEN SYNTHESIS; ENVIRONMENTAL FACTOR; FRACTURE; GENETIC SUSCEPTIBILITY; HUMAN; NONHUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

3' UNTRANSLATED REGIONS; ANIMALS; BONE DENSITY; CHROMOSOME MAPPING; COLLAGEN; CYTOKINES; ESTROGEN RECEPTOR ALPHA; GENETIC MARKERS; HUMANS; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RECEPTORS, ESTROGEN; SP1 TRANSCRIPTION FACTOR;

EID: 0035134345     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01149.x     Document Type: Review

References (102)

1. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women
2. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: A study of postmenopausal twins
3. Polymorphism of the collagen type Ialphal gene and ethnic differences in hip-fracture rates
4. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains
5. Regulation of expression of the alpha 1 (I) collagen gene: A critical appraisal of the role of the first intron
6. Apolipoprotein E polymorphism. A new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures
7. The vitamin D receptor start codon polymorphism (Fok1) and bone mineral density in premenopausal women in Taiwan
8. Heritability of bone mass: A longitudinal study in ageing male twins
9. Osteoblasts are a new target for prolactin analysis of bone formation in prolactin receptor knockout mice
10. Bone mass in middle-aged osteoporotic men and their relatives: Familial effect
11. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
12. Risk factors for hip fracture in white women
13. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2 (I) chains which are not incorporated into trimers of type I procollagen
14. Relationship between COLIA1 Sp1 alleles, gene transcription, collagen production and bone strength
15. Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture
16. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q
17. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis Study
18. A novel polymorphism in the promoter region for the human osteocalcin gene: The possibility of a correlation with bone mineral density in postmenopausal Japanese women
19. Increased bone formation in osteocalcin-deficient mice
20. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis
21. The BsmI vitamin D. Receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women
22. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis
23. Low serum IGF-1 and occurance of osteoporotic fractures in postmenopausal women
24. The association of bone mineral density with vitamin D receptor gene polymorphisms
25. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13
26. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization
27. The effect of Vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor Genotype
28. Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I alpha 1 gene
29. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women
30. Segregation analysis and variance components analysis of bone mineral density in healthy families
31. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population
32. Genetic and environmental correlations between bone formation and bone mineral density, a twin study
33. Genetic mapping of recessive osteopetrosis to 11q12-13
34. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
35. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women
36. Polymorphism at an Sp1 binding site of COL1A1 and bone mineral density in premenopausal female twins and elderly fracture patients
37. Vitamin D. Receptor genotype and breast cancer in Latinas (United States)
38. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)
39. Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: Cross sectional and longitudinal population study
40. Genetic factors and osteoporotic fractures in elderly people: Prospective 25 year follow up of a nationwide cohort of elderly Finnish twins
41. Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover
42. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
43. Genetic factors in bone turnover
44. Changes in axial bone density with age: A twin study
45. The BsmI vitamin D. Restriction fragment length plymorphism (bb) influences the effect of calcium intake on bone mineral density
46. Early and late postmenopausal bone loss is associated with BsmI vitamin D receptor gene polymorphism in Japanese women
47. Quantitative trait loci affecting peak bone mineral density in mice
48. Association of bone mineral density with polymorphism of the estrogen receptor gene
49. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
50. Vitamin D. Receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake
51. Mutation of the mouse klotho gene leads to a syndrome resembling ageing
52. Genetic dissection of complex traits
53. A sequence variation. 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
54. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene
55. An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women
56. A. Polymorphism in the human GALR3 galanin receptor gene (GALNR3)
57. Vitamin D. Receptor gene polymorphisms and bone mineral density in elderly Chinese men and women in Hong Kong
58. Osteopetrosis and osteoporosis: Two sides of the same coin
59. Mice deficient in Ab1 are osteoporotic and have defects in osteoblast maturation
60. Polymorphism at the Sp 1 binding site in the collagen type I alpha 1 gene does not predict bone mineral density in postmenopausal women in Sweden
61. VDR. Genotype and response to etidronate therapy in late postmenopausal women
62. Polymorphism of insulin-like growth factor I gene and bone mineral density
63. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women
64. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
65. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: Lack of correspondence with common allelic variants
66. Prediction of bone density from vitamin D receptor alleles
67. Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin
68. Polymorphisms of the Interleukin-6 Gene are associated with bone mineral density
69. Ethnic difference in contribution of Sp1 site variation of COLIA1 gene in genetic predisposition to osteoporosis
70. A genome-wide scan for loci linked to forearm bone mineral density
71. Influence of heredity and environment on bone density in adolescent boys: A parent-offspring study
72. Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts
73. Statistical approaches to gene mapping
74. Vitamin D binding protein gene in male osteoporosis: Association of plasma DBP and bone mineral density with (TAAA) (n)-Alu polymorphism in DBP
75. Genetic determinants of bone mass in adults. A twin study
76. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta
77. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent
78. Apolipoprotein E. Gene polymorphism and bone loss: Estrogen status modifies the influence of apolipoprotein E on bone loss
79. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
80. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants
81. Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain
82. Osteoprotegerin. A novel secreted protein involved in the regulation of bone density
83. Estrogen resistance caused by a mutation in the estrogen- receptor gene in a man
84. Genetic factors in determining bone mass
85. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
86. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density
87. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women
88. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus
89. Investigation of the relationship between osteoporosis and the collagenase gene by means of polymorphism of the 5′upstream region of this gene
90. Genetic influences on type I collagen synthesis and degradation: Further evidence for genetic regulation of bone turnover
91. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
92. Prediction of perimenopausal fractures by bone mineral density and other risk factors
93. Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus
94. Vitamin D. Receptor genotype is associated with radiographic osteoarthritis at the knee
95. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
96. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women
97. Bone and haematopoietic defects in mice lacking c-fos
98. COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures
99. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
100. Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis
101. Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents
102. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women